In September 2006, Kensey Nash received regulatory clearance for the OsseoFit™ Bone Void Filler. The OsseoFit Device is a unique implant manufactured from Kensey Nash’s proprietary Porous Tissue Matrix™ Technology (PTM), which creates foamed scaffolds suited for tissue engineering applications. The OsseoFit PTM Device utilizes several resorbable biomaterials including a proprietary collagen formulation, synthetic polymer and ceramic. This unique design provides a stable platform for cell in-growth that will ultimately be replaced completely by bone during the healing process.

The OsseoFit PTM Device is intended to be gently packed into bone voids or bone defects in the pelvis and extremities. Bone voids and defects can be formed as the result of trauma or purposely created surgically as osseous defects for the harvest of bone. The Device has a unique architecture that provides a stable platform, which quickly absorbs surrounding blood and marrow, allowing for cell in-growth thus leading to the repair of bone. Pre-clinical studies in a well-accepted bone void filler model have shown the OsseoFit PTM device to successfully promote normal gross bone repair. The device may be combined with sterile fluids such as saline or autogenous blood products such as blood or bone marrow aspirate.

The OsseoFit PTM Device is available in the following sizes: 4, 6, 8, 10, 12 and 15mm in diameter and a standard length of 15 mm. Devices are housed in an easy to use insertion instrument that allows the surgeon to modify the device to its appropriate length then easily dispense the implant into the bone void or defect.

OsseoFit™ Porous Tissue Matrix™ products are manufactured by Kensey Nash Corporation and exclusively marketed and distributed by Biomet Sports Medicine, Inc. OsseoFit™ is a trademark of Biomet Sports Medicine, Inc. and Porous Tissue Matrix™ is a trademark of Kensey Nash Corporation.

. Visit Biomet Here